Arctic Bioscience AS maintained earnings guidance for the year 2022. The Company maintains the earlier communicated financial outlook of a y/y revenue growth in 2022 of 60-70 %.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.7 NOK | 0.00% | -5.83% | -7.62% |
Mar. 01 | Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 01 | Transcript : Arctic Bioscience AS, Q4 2023 Earnings Call, Mar 01, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.62% | 23.02M | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- ABS Stock
- News Arctic Bioscience
- Arctic Bioscience as Maintains Earnings Guidance for the Year 2022